Steve Valiquette
Stock Analyst at Barclays
(1.53)
# 3,465
Out of 5,163 analysts
147
Total ratings
47.42%
Success rate
-1.95%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Maintains: Equal-Weight | $8 → $9.5 | $13.94 | -31.85% | 6 | Nov 10, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $5.37 | +123.46% | 13 | Oct 31, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $940.91 | -34.53% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $2.24 | +301.79% | 7 | Mar 1, 2024 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $17.98 | +33.48% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $76.13 | +12.96% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $34.45 | +146.73% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $532.97 | -43.71% | 4 | Jun 28, 2023 | |
| LTC LTC Properties | Maintains: Underweight | $35 → $34 | $39.10 | -13.04% | 3 | May 3, 2023 | |
| THC Tenet Healthcare | Maintains: Overweight | $70 → $105 | $227.63 | -53.87% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $86.56 | -36.46% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $20.62 | -36.95% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $192.42 | -26.20% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $35.07 | -85.74% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $100.37 | -43.21% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $207.82 | -60.54% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $16.98 | +6.01% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $48.05 | -35.48% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $149.20 | +151.34% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $40.03 | -52.54% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $165.43 | +244.56% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $217.08 | -70.52% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $267.19 | +16.02% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $282.09 | +100.29% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $1.59 | +4,616.98% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $8.39 | +126.46% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $3.20 | +212.50% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $6.96 | +187.36% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $78.27 | +232.18% | 1 | Feb 19, 2021 |
Brookdale Senior Living
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $8 → $9.5
Current: $13.94
Upside: -31.85%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $5.37
Upside: +123.46%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $940.91
Upside: -34.53%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $2.24
Upside: +301.79%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $17.98
Upside: +33.48%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $76.13
Upside: +12.96%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $34.45
Upside: +146.73%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $532.97
Upside: -43.71%
LTC Properties
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $39.10
Upside: -13.04%
Tenet Healthcare
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $227.63
Upside: -53.87%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $86.56
Upside: -36.46%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $20.62
Upside: -36.95%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $192.42
Upside: -26.20%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $35.07
Upside: -85.74%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $100.37
Upside: -43.21%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $207.82
Upside: -60.54%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $16.98
Upside: +6.01%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $48.05
Upside: -35.48%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $149.20
Upside: +151.34%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $40.03
Upside: -52.54%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $165.43
Upside: +244.56%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $217.08
Upside: -70.52%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $267.19
Upside: +16.02%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $282.09
Upside: +100.29%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $1.59
Upside: +4,616.98%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $8.39
Upside: +126.46%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $3.20
Upside: +212.50%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $6.96
Upside: +187.36%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $78.27
Upside: +232.18%